- 300 mg as Abacavir sulfate
Without a Prescription
Abacavir 300 mg tablets are prescribed for the treatment of HIV-1 infection in combination with other antiretroviral agents.
Additional important information on the use of Abacavir for treatment of HIV-1 infection:
Abacavir is one of multiple products containing abacavir.
Before starting Abacavir, review medical history for prior exposure to any abacavir containing product in order to avoid
reintroduction in a patient with a history of hypersensitivity to abacavir.
Abacavir may be taken with or without food.
Abacavir recommended dose for adults is:
600 mg once daily in combination with other antiretroviral agents or 600 mg daily administered as either 300 mg twice daily.
Patients with Hepatic Impairment:
Abacavir recommended dose in patients with mild hepatic impairment is 200 mg twice daily. To enable dose reduction, Abacavir(10 mL twice daily) should be prescribed for the treatment of these patients. The safety, efficacy, and pharmacokinetic
properties of Abacavir have not been established in patients with moderate to severe hepatic impairment, and therefore
Abacavir is contraindicated in these patients.
Abacavir tablets are contraindicated in patients with:
- Moderate or severe hepatic impairment;
- Previously demonstrated hypersensitivity to abacavir;
- Never restart Abacavir or any other abacavir-containing product following a hypersensitivity reaction to abacavir;
Container of 30 tablets